LYN-100

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLYN-100
Drug Alias NameLYN-100
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLynkogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLynkogen Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A